Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $115B
1-Year Return 4.22%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Quarter Return
+1.9%
1 Year Return
+4.22%
3 Year Return
+14.25%
5 Year Return
+23%
10 Year Return
+57.51%
AUM
$95.1B
AUM Growth
+$5.84B
Cap. Flow
-$9.46B
Cap. Flow %
-9.95%
Top 10 Hldgs %
6.22%
Holding
7,189
New
1,945
Increased
2,177
Reduced
1,926
Closed
765

Top Buys

1
AMZN icon
Amazon
AMZN
+$612M
2
MBB icon
iShares MBS ETF
MBB
+$487M
3
BIDU icon
Baidu
BIDU
+$451M
4
CMCSA icon
Comcast
CMCSA
+$431M
5
NVDA icon
NVIDIA
NVDA
+$426M

Sector Composition

1 Technology 16.04%
2 Healthcare 13.8%
3 Consumer Discretionary 10.31%
4 Financials 9.94%
5 Industrials 7.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADERW
5476
DELISTED
26 Capital Acquisition Corp. Warrant
ADERW
$147K ﹤0.01%
+186,449
New +$147K
DMS
5477
DELISTED
Digital Media Solutions, Inc.
DMS
$147K ﹤0.01%
799
-106
-12% -$19.5K
ETTX
5478
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$147K ﹤0.01%
68,574
+14,458
+27% +$31K
SEAH.U
5479
DELISTED
Sports Entertainment Acquisition Corp. Units, each consisting of one share of Class A Common Stock,
SEAH.U
$147K ﹤0.01%
+14,345
New +$147K
SPNV.U
5480
DELISTED
Supernova Partners Acquisition Company, Inc. Units, each consisting of one share of Class A common s
SPNV.U
$147K ﹤0.01%
+13,750
New +$147K
KXIN icon
5481
Kaixin Holdings
KXIN
$8.12M
$146K ﹤0.01%
49
+28
+133% +$83.4K
VIAO
5482
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$146K ﹤0.01%
11,320
-318
-3% -$4.1K
ADERU
5483
DELISTED
26 Capital Acquisition Corp. Unit
ADERU
$146K ﹤0.01%
+14,575
New +$146K
EMBKW
5484
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$146K ﹤0.01%
+126,127
New +$146K
NAACW
5485
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$146K ﹤0.01%
+244,050
New +$146K
FVT.WS
5486
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$146K ﹤0.01%
+140,000
New +$146K
MRACU
5487
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$146K ﹤0.01%
14,328
-1,392,690
-99% -$14.2M
RAACU
5488
DELISTED
Revolution Acceleration Acquisition Corp Unit
RAACU
$146K ﹤0.01%
13,530
-1,234,922
-99% -$13.3M
KALA icon
5489
KALA BIO
KALA
$131M
$145K ﹤0.01%
431
-1,177
-73% -$396K
BPTH
5490
DELISTED
Bio-Path Holdings Inc
BPTH
$145K ﹤0.01%
+1,030
New +$145K
ACHV icon
5491
Achieve Life Sciences
ACHV
$157M
$144K ﹤0.01%
+12,456
New +$144K
ADTX
5492
Aditxt
ADTX
$5.03M
0
EFOI icon
5493
Energy Focus
EFOI
$13.4M
$144K ﹤0.01%
+4,471
New +$144K
TOI icon
5494
The Oncology Institute
TOI
$285M
$144K ﹤0.01%
+14,448
New +$144K
PV.WS
5495
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$144K ﹤0.01%
+175,000
New +$144K
AGCUU
5496
DELISTED
Altimeter Growth Corp. Unit
AGCUU
$144K ﹤0.01%
+11,789
New +$144K
GBR icon
5497
New Concept Energy
GBR
$5.65M
$143K ﹤0.01%
+33,444
New +$143K
LINC icon
5498
Lincoln Educational Services
LINC
$622M
$143K ﹤0.01%
+22,268
New +$143K
NNVC icon
5499
NanoViricides
NNVC
$23.3M
$143K ﹤0.01%
+30,342
New +$143K
PCSA icon
5500
Processa Pharmaceuticals
PCSA
$9.55M
$143K ﹤0.01%
+656
New +$143K